Share on StockTwits

The FDA granted accelerated approval to Merck’s drug, Keytruda, meant to treat melanoma that has spread or that can’t be surgically removed.

“FDA approves new melanoma-fighting cancer drug” is categorized as “world”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.